Schechter Adam H
President & CEO at LH; EVP & Pres-Global Human Health at MRK; President, Global Pharms at MERCK & CO INC
- Sold, on record
- $80.7M
- Dollars the filings state
- Form 4 sales
- 25
- Latest Aug 11, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- LHLABCORP HOLDINGS INC.President & CEO
- MRKMerck & Co., Inc.EVP & Pres-Global Human Health
- MERCK & CO INCPresident, Global Pharms
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- MRK991,981 shares
- LH55,616 shares
- MERCK & CO INC36,676 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale LHRoutineFeb 11, 2025 2025
Sold 6,121 shares at $244.62 ($1.5M)
Schechter Adam H, President & CEO
10b5-1 planSold 6.6% of holdings ($22.6M position)86,445 shares leftFiling
- 2 Form 4 sale LHRoutineMay 12, 2025 +90 days
Sold 6,105 shares at $248.73 ($1.5M)
Schechter Adam H, President & CEO
10b5-1 planSold 5.8% of holdings ($26.1M position)98,962 shares leftFiling
- 3 Form 4 sale LHRoutineAug 11, 2025 +91 days
Sold 5,643 shares at $266.78 ($1.5M)
Schechter Adam H, President & CEO
10b5-1 planSold 5.7% of holdings ($26.4M position)93,319 shares left0.9x usual sizeFiling
- 4 Form 4 sale LHRoutineNov 11, 2025 +92 days
Sold 5,745 shares at $262.75 ($1.5M)
Schechter Adam H, President & CEO
10b5-1 planSold 6.2% of holdings ($24.5M position)87,574 shares left0.9x usual sizeFiling
- 5 Form 4 sale LHRoutineFeb 11, 2026 +92 days
Sold 5,273 shares at $284.38 ($1.5M)
Schechter Adam H, President & CEO
10b5-1 planSold 5.7% of holdings ($26.3M position)87,343 shares left0.9x usual sizeFiling
- 6 Form 4 sale LHNo planMar 3, 2026 +20 days
Sold 8,705 shares at $279.96 ($2.4M)
Schechter Adam H, President & CEO
No 10b5-1 planSold 9.7% of holdings ($25.1M position)80,773 shares left1.5x usual sizeFiling
- 7 Form 4 sale LHRoutineMay 11, 2026 +69 days
Sold 5,903 shares at $254.50 ($1.5M)
Schechter Adam H, President & CEO
10b5-1 planSold 5.2% of holdings ($28.8M position)107,234 shares left1x usual sizeFiling
- 8 Form 4 sale LHRoutineAug 11, 2026 +92 days
Sold 4,669 shares at $320.37 ($1.5M)
Schechter Adam H, President & CEO
10b5-1 planSold 4.4% of holdings ($34.4M position)102,565 shares left0.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (26)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Aug 12, 2026 | LH | President & CEO | Form 4 sale | 4,669 | $1.5M | 4.4% | Routine | SEC |
| May 11, 2026 | May 13, 2026 | LH | President & CEO | Form 4 sale | 5,903 | $1.5M | 5.2% | Routine | SEC |
| Mar 3, 2026 | Mar 5, 2026 | LH | President & CEO | Form 4 sale | 8,705 | $2.4M | 9.7% | No plan | SEC |
| Feb 11, 2026 | Feb 13, 2026 | LH | President & CEO | Form 4 sale | 5,273 | $1.5M | 5.7% | Routine | SEC |
| Nov 11, 2025 | Nov 13, 2025 | LH | President & CEO | Form 4 sale | 5,745 | $1.5M | 6.2% | Routine | SEC |
| Aug 11, 2025 | Aug 13, 2025 | LH | President & CEO | Form 4 sale | 5,643 | $1.5M | 5.7% | Routine | SEC |
| May 12, 2025 | May 13, 2025 | LH | President & CEO | Form 4 sale | 6,105 | $1.5M | 5.8% | Routine | SEC |
| Feb 11, 2025 | Feb 13, 2025 | LH | President & CEO | Form 4 sale | 6,121 | $1.5M | 6.6% | Routine | SEC |
| Nov 12, 2024 | Nov 12, 2024 | LH | Officer, Director | Form 144 notice | 6,189 | $1.5M | Notice | SEC | |
| Nov 11, 2024 | Nov 13, 2024 | LH | President & CEO | Form 4 sale | 6,189 | $1.5M | 6.6% | Routine | SEC |
| Nov 1, 2018 | Nov 2, 2018 | MRK | EVP & Pres-Global Human Health | Form 4 sale | 277,879 | $20.5M | 100.0% | Unusual | SEC |
| Sep 17, 2018 | Sep 18, 2018 | MRK | EVP & Pres-Global Human Health | Form 4 sale | 107,360 | $7.5M | 100.0% | Unusual | SEC |
| Jun 18, 2018 | Jun 19, 2018 | MRK | EVP & Pres-Global Human Health | Form 4 sale | 134,094 | $8.2M | 100.0% | Unusual | SEC |
| Feb 8, 2018 | Feb 9, 2018 | LH | Director | Form 4 sale | 1,263 | $214k | 17.3% | Plan not stated | SEC |
| Jan 16, 2018 | Jan 16, 2018 | MRK | EVP & Pres-Global Human Health | Form 4 sale | 101,602 | $6.3M | 100.0% | Unusual | SEC |
| Apr 3, 2017 | Apr 4, 2017 | MRK | EVP & Pres-Global Human Health | Form 4 sale | 53,850 | $3.4M | 31.6% | Unusual | SEC |
| Feb 3, 2017 | Feb 6, 2017 | MRK | EVP & Pres-Global Human Health | Form 4 sale | 36,335 | $2.3M | 100.0% | Unusual | SEC |
| Sep 1, 2016 | Sep 1, 2016 | MRK | EVP & Pres-Global Human Health | Form 4 sale | 39,200 | $2.5M | 100.0% | Unusual | SEC |
| Jul 1, 2016 | Jul 1, 2016 | MRK | EVP & Pres-Global Human Health | Form 4 sale | 50,000 | $2.9M | 100.0% | Unusual | SEC |
| May 11, 2015 | May 11, 2015 | MRK | EVP & Pres-Global Human Health | Form 4 sale | 10,634 | $643k | 100.0% | Unusual | SEC |
| Jan 15, 2015 | Jan 15, 2015 | MRK | EVP & Pres-Global Human Health | Form 4 sale | 74,200 | $4.6M | 100.0% | Unusual | SEC |
| Aug 25, 2014 | Aug 25, 2014 | MRK | EVP & Pres-Global Human Health | Form 4 sale | 22,000 | $1.3M | 23.7% | Plan not stated | SEC |
| May 14, 2014 | May 14, 2014 | MRK | EVP & Pres-Global Human Health | Form 4 sale | 10,527 | $589k | 100.0% | Unusual | SEC |
| Feb 11, 2014 | Feb 13, 2014 | MRK | EVP & Pres-Global Human Health | Form 4 sale | 18,000 | $1M | 100.0% | Unusual | SEC |
| Nov 5, 2012 | Nov 6, 2012 | MRK | EVP & Pres-Global Human Health | Form 4 sale | 56,300 | $2.6M | 79.1% | Unusual | SEC |
| Feb 15, 2008 | Feb 19, 2008 | MERCK & CO INC | President, Global Pharms | Form 4 sale | 36,676 | $1.7M | 100.0% | Unusual | SEC |